Synergistic Peptide-based Vaccination Systems
Legal Citation
Summary of the Inventive Concept
Integrating peptide-based vaccines with AI, IoT, blockchain, and nanomaterials to create powerful, personalized, and secure vaccination systems.
Background and Problem Solved
The original patent disclosed peptide-based vaccines for antimicrobial prophylaxis and therapy, but it had limitations in terms of personalization, data tracking, and security. The new inventive concept addresses these limitations by combining the peptide-based vaccines with cutting-edge technologies to create a more effective, efficient, and secure system.
Detailed Description of the Inventive Concept
The inventive concept integrates a peptide-based vaccine with an AI-powered analytics engine for tracking and predicting immune responses, a blockchain-based secure data storage module for storing vaccination records and tracking vaccine efficacy, and an IoT-enabled monitoring device for real-time monitoring of vaccine administration and efficacy. The system can be further personalized by optimizing peptide sequences using machine learning algorithms and tailoring vaccination schedules to an individual's genetic profile.
Novelty and Inventive Step
The new claims introduce a synergistic combination of peptide-based vaccines with AI, IoT, blockchain, and nanomaterials, which provides a non-obvious solution to the limitations of the original patent. The integration of these technologies enables a more effective, efficient, and secure vaccination system that is not anticipated by the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include using different AI algorithms for analytics, incorporating additional sensors or monitoring devices, or integrating with existing healthcare infrastructure. Variations could include using different peptide sequences, adjuvants, or delivery vehicles, or applying the system to different diseases or applications.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the vaccine and pharmaceutical industries, particularly in the areas of personalized medicine, infectious disease prevention, and antimicrobial resistance. The system's ability to provide secure, real-time tracking and monitoring of vaccine efficacy and administration could also have applications in public health and epidemiology.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K39/104 |
| C | C07 | C07K14/212 |
| A | A61 | A61K2039/543 |
| A | A61 | A61K2039/55505 |
| A | A61 | A61K2039/55566 |
| G | G01 | G01N2333/22 |
| G | G01 | G01N2469/20 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biotechnology, immunology, and vaccine development, with expertise in peptide-based vaccine design, bioinformatics, and advanced medical technologies
Person of Ordinary Skill (PHOSITA) Profile
A skilled researcher with advanced degrees in biotechnology or molecular biology, familiar with vaccine development techniques, AI/machine learning applications in biological research, and emerging digital health technologies
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with peptide-based vaccine development represents a natural progression of existing biotechnological approaches. The combination of AI, blockchain, and IoT with peptide vaccine design follows established patterns of technological convergence in medical research. The proposed variations represent predictable extensions of known techniques in vaccine development and digital health monitoring.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,615 |
|---|---|
| Title | Peptides derived from Acinetobacter baumannii and their use in vaccination |
| Assignee(s) | Evaxion Biotech A/S |